Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Assets (2017 - 2024)

Historic Non-Current Assets for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $32.3 million.

  • Solid Biosciences' Non-Current Assets fell 1113.19% to $32.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $32.3 million, marking a year-over-year decrease of 7889.91%. This contributed to the annual value of $35.2 million for FY2023, which is 1331.81% down from last year.
  • Latest data reveals that Solid Biosciences reported Non-Current Assets of $32.3 million as of Q3 2024, which was down 1113.19% from $33.4 million recorded in Q2 2024.
  • Over the past 5 years, Solid Biosciences' Non-Current Assets peaked at $40.6 million during Q4 2022, and registered a low of $8.9 million during Q1 2022.
  • Moreover, its 5-year median value for Non-Current Assets was $32.3 million (2024), whereas its average is $24.8 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 3159.37% in 2021, then skyrocketed by 33567.28% in 2023.
  • Solid Biosciences' Non-Current Assets (Quarter) stood at $12.3 million in 2020, then fell by 20.38% to $9.8 million in 2021, then surged by 315.79% to $40.6 million in 2022, then dropped by 13.32% to $35.2 million in 2023, then decreased by 8.16% to $32.3 million in 2024.
  • Its Non-Current Assets was $32.3 million in Q3 2024, compared to $33.4 million in Q2 2024 and $34.5 million in Q1 2024.